Canine Atopic Dermatitis Treatment Drugs Market, by Drug Class (Janus Kinase Inhibitors, Immunosuppressant, Monoclonal Antibody, Antibiotics, and Others), by Route of Administration (Injection, Oral, and Topical), by Distribution Channel (Hospital and Clinics, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
Canine atopic dermatitis is an inflammatory, chronic skin disease associated with allergies. This is the second most common allergic skin disease in dogs. The major cause of atopic dermatitis in dogs is harmful allergen such as animal dander, airborne pollens, mold spores, and house dust. This disease in dogs is often hereditary and exposure to any harmful allergen can trigger the onset of canine atopic dermatitis. Its symptoms include excessive itching and scratching, hair loss, greasy or flaky skin with a foul odor, and excessive scratching on the paws and areas such as the groin and armpits.
Market Dynamics
The global canine atopic dermatitis treatment drugs market is expected to witness high growth over the forecast period, owing to increasing pet ownership.
However, the high cost associated with cyclosporine, glucocorticoids, immunotherapy, and oral histamines treatment therapies is a major factor restraining the global canine atopic dermatitis treatment drugs market growth. For instance, the cost of canine atopic dermatitis treatment ranges from US$ 600 to US$ 1,100 depending on the type and severity of atopic dermatitis. An additional cost of diagnostic tests, sedation for injection, and others may include more than US$ 200 to US$ 300.
Key features of the study:
- This report provides an in-depth analysis of the global canine atopic dermatitis treatment drugs market, market size (US$ Mn), and compound annual growth rate (CAGR %) during the forecast period: 2021 – 2028, considering 2020 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players operating in this market
- It profiles key players in the global canine atopic dermatitis treatment drugs market based on the following parameters–company overview, financial performance, product portfolio, geographical presence, key developments, and strategies.
- Key players covered as a part of this study include Zoetis Inc., Elanco Animal Health Incorporated, Virbac, Kindred Biosciences, Inc., Nippon Zenyaku Kogyo Co., Ltd. (ZENOAQ), Bioiberica S.A.U, Dechra Pharmaceuticals PLC, and Toray Industries, Inc.
- Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
- The global canine atopic dermatitis treatment drugs market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for global canine atopic dermatitis treatment drugs market, research and consulting firms, new entrants, and financial analysts
- Global Canine Atopic Dermatitis Treatment Drugs Market, By Drug Class:
- Janus Kinase Inhibitors
- Immunosuppressant
- Monoclonal Antibody
- Antibiotics
- Others
- Global Canine Atopic Dermatitis Treatment Drugs Market, By Route of Administration:
- Injection
- Oral
- Topical
- Global Canine Atopic Dermatitis Treatment Drugs Market, By Distribution Channel:
- Hospital and Clinics
- Retail Pharmacies
- Online Pharmacies
- Global Canine Atopic Dermatitis Treatment Drugs Market, By Region:
- North America
- By Country:
- U.S.
- Canada
- By Drug Class:
- Janus kinase Inhibitors
- Immunosuppressant
- Monoclonal Antibody
- Antibiotics
- Others
- By Route of Administration:
- Injection
- Oral
- Topical
- By Distribution Channel
- Hospital and Clinics
- Retail Pharmacies
- Online Pharmacies
- Europe
- By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- By Drug Class:
- Janus kinase Inhibitors
- Immunosuppressant
- Monoclonal Antibody
- Antibiotics
- Others
- By Route of Administration:
- Injection
- Oral
- Topical
- By Distribution Channel
- Hospital and Clinics
- Retail Pharmacies
- Online Pharmacies
- Asia Pacific
- By Country:
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- By Drug Class:
- Janus kinase Inhibitors
- Immunosuppressant
- Monoclonal Antibody
- Antibiotics
- Others
- By Route of Administration:
- Injection
- Oral
- Topical
- By Distribution Channel
- Hospital and Clinics
- Retail Pharmacies
- Online Pharmacies
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Drug Class:
- Janus kinase Inhibitors
- Immunosuppressant
- Monoclonal Antibody
- Antibiotics
- Others
- By Route of Administration:
- Injection
- Oral
- Topical
- By Distribution Channel
- Hospital and Clinics
- Retail Pharmacies
- Online Pharmacies
- Middle East
- By Country:
- GCC
- Israel
- Rest of Middle East
- By Drug Class:
- Janus kinase Inhibitors
- Immunosuppressant
- Monoclonal Antibody
- Antibiotics
- Others
- By Route of Administration:
- Injection
- Oral
- Topical
- By Distribution Channel
- Hospital and Clinics
- Retail Pharmacies
- Online Pharmacies
- Africa
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- By Drug Class:
- Janus kinase Inhibitors
- Immunosuppressant
- Monoclonal Antibody
- Antibiotics
- Others
- By Route of Administration:
- Injection
- Oral
- Topical
- By Distribution Channel
- Hospital and Clinics
- Retail Pharmacies
- Online Pharmacies
- Company Profiles
- Zoetis Inc.*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Elanco Animal Health Incorporated
- Virbac
- Kindred Biosciences, Inc.
- Nippon Zenyaku Kogyo Co., Ltd. (ZENOAQ)
- Bioiberica S.A.U
- Dechra Pharmaceuticals PLC
- Toray Industries, Inc.
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Form Factor
- Market Snippet, By Technology
- Market Snippet, By Application
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Regulatory Scenario
- Industry Trend
- Merger and Acquisitions
- New system Launch/Approvals
- 4. Global Femtocell Market, By Form Factor, 2017-2028 (US$ Million)
- Introduction
- Market Share Analysis, 2020 and 2028 (%)
- Segment Trends
- Standalone
- Introduction
- Market Size and Forecast, 2017–2028, (US$ Million)
- Integrated
- Introduction
- Market Size and Forecast, 2017–2028, (US$ Million)
- 5. Global Femtocell Market, By Technology, 2017-2028 (US$ Million)
- Introduction
- Market Share Analysis, 2020 and 2028 (%)
- Segment Trends
- 2G
- Introduction
- Market Size and Forecast, 2017–2028, (US$ Million)
- 3G
- Introduction
- Market Size and Forecast, 2017–2028, (US$ Million)
- 4G
- Introduction
- Market Size and Forecast, 2017–2028, (US$ Million)
- 6. Global Femtocell Market, By Application, 2017-2028 (US$ Million)
- Introduction
- Market Share Analysis, 2020 and 2028 (%)
- Segment Trends
- In-house
- Introduction
- Market Size and Forecast, 2017–2028, (US$ Million)
- Corporate
- Introduction
- Market Size and Forecast, 2017–2028, (US$ Million)
- Public
- Introduction
- Market Size and Forecast, 2017–2028, (US$ Million)
- 7. Global Femtocell Market, By Region, 2017-2028 (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2020 and 2028 (%)
- North America
- Regional Trends
- Market Size and Forecast, By Form Factor, 2017–2028 (US$ Million)
- Market Size and Forecast, By Technology, 2017–2028 (US$ Million)
- Market Size and Forecast, By Application, 2017–2028 (US$ Million)
- Market Share Analysis, By Country, 2020 and 2028 (%)
- U.S.
- Canada
- Western Europe
- Regional Trends
- Market Size and Forecast, By Form Factor, 2017–2028 (US$ Million)
- Market Size and Forecast, By Technology, 2017–2028 (US$ Million)
- Market Size and Forecast, By Application, 2017–2028 (US$ Million)
- Market Share Analysis, By Country, 2020 and 2028 (%)
- U.K.
- Germany
- Italy
- France
- Rest of Europe
- Eastern Europe
- Regional Trends
- Market Size and Forecast, By Form Factor, 2017–2028 (US$ Million)
- Market Size and Forecast, By Technology, 2017–2028 (US$ Million)
- Market Size and Forecast, By Application, 2017–2028 (US$ Million)
- Market Share Analysis, By Country, 2020 and 2028 (%)
- Poland
- Russia
- Rest of Eastern Europe
- Asia Pacific
- Regional Trends
- Market Size and Forecast, By Form Factor, 2017–2028 (US$ Million)
- Market Size and Forecast, By Technology, 2017–2028 (US$ Million)
- Market Size and Forecast, By Application, 2017–2028 (US$ Million)
- Market Share Analysis, By Country, 2020 and 2028 (%)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Regional Trends
- Market Size and Forecast, By Form Factor, 2017–2028 (US$ Million)
- Market Size and Forecast, By Technology, 2017–2028 (US$ Million)
- Market Size and Forecast, By Application, 2017–2028 (US$ Million)
- Market Share Analysis, By Country, 2020 and 2028 (%)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East and Africa
- Regional Trends
- Market Size and Forecast, By Form Factor, 2017–2028 (US$ Million)
- Market Size and Forecast, By Technology, 2017–2028 (US$ Million)
- Market Size and Forecast, By Application, 2017–2028 (US$ Million)
- Market Share Analysis, By Country, 2020 and 2028 (%)
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
- 8. Competitive Landscape
- Company Profiles
- Airvana LLC
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Texas Instruments Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Alcatel-Lucent SA
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Samsung Electronics
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Cisco Systems Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Nokia Solution, and Networks
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Telefonaktiebolaget LM Ericsson
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Netgear, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Gemtek technology Corp.
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- NEC Corporation
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- ip.access, Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- 9. Section
- References
- Research Methodology
- About us and Sales Contact
- *Browse XX market data tables and XX figures on “Global Femtocell Market-forecast to 2028”.
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook